MI

AI Stocks in the Cloud - More Growth to Come

Retrieved on: 
Tuesday, April 2, 2024
Cloud, Supercluster, Artificial intelligence, LLM, Partnership, Minority, InfiniBand, UPS, Multilateral, Central processing unit, Organization, Loan, KSUM, Memory, Blue Yonder, News, SAP, AI, Cloud computing, Magnetar Capital, Growth, WKN, Genius, Graphics processing unit, Wayfinder, Total

Among the myriad applications of AI, the integration of AI into cloud computing has proven to be a game-changer, giving rise to the Cloud AI market.

Key Points: 
  • Among the myriad applications of AI, the integration of AI into cloud computing has proven to be a game-changer, giving rise to the Cloud AI market.
  • Leveraging its industry-leading partners, Cedarcross is poised to drive streamlined growth and innovation in the AI sector.
  • Supermicro, Inc., a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, just announced its latest portfolio to accelerate the deployment of generative AI.
  • Cost savings, which are a result of AI being used in cloud computing, are one of these benefits that stand out for efficiency."

Amcomri Entertainment Announces Extension to Existing Credit Facilities

Retrieved on: 
Tuesday, April 9, 2024
Minority, United States dollar, OTC, Bank

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. (“Amcomri” or the “Company”) (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) is pleased to announce that the Company has amended and restated its existing credit facilities.

Key Points: 
  • VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. (“Amcomri” or the “Company”) (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) is pleased to announce that the Company has amended and restated its existing credit facilities.
  • The Company amended and restated the agreements governing the Company’s US$1.25 million credit facility and US$3.2 million working capital facility to extend the term of the loans to June 30, 2024.
  • Amounts drawn under the credit facilities remain repayable by the Company at any time without penalty.
  • The Company did not file a material change report 21 days in advance of implementing the transactions as the negotiations were only recently concluded.

Rio2 Announces Upsize of Private Placement Up to C$23 Million

Retrieved on: 
Tuesday, April 9, 2024
TSX Venture Exchange, Project, Offering, Rule, Minority, Part, Sale, Regulation, News, National instrument, Issuer, BVL, Security (finance)

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) -- Rio2 Limited (“Rio2” or the “Company”) (TSXV: RIO; OTCQX: RIOFF; BVL: RIO) is pleased to announce that further to the news release dated April 8, 2024, it has entered into an amending agreement with Eight Capital, as agent, to upsize the previously announced private placement. Pursuant to the upsized offering, the Company will issue up to 59,030,000 common shares of the Company (the “Shares”) at a price of $0.39 per Share (the “Offering Price”) for gross proceeds to the Company of up to $23,021,700 (the “Offering”).

Key Points: 
  • Alex Black, Executive Chairman, stated: “The Company received significant interest from key existing shareholders to participate in financing our Company at this stage of its development, far exceeding the $10 million maximum amount first announced.
  • The LIFE Shares issued to Canadian resident subscribers in the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws.
  • The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “U.S.
  • Securities Act”) or under any U.S. state securities laws, and may not be offered or sold in the United States or to “U.S.

Visteon to Announce First Quarter 2024 Results on April 25

Retrieved on: 
Tuesday, April 9, 2024
VAN, Webcast, Visteon, News, Internet service provider

VAN BUREN TOWNSHIP, Mich., April 09, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its first quarter 2024 financial results before the market opens on Thursday, April 25.

Key Points: 
  • VAN BUREN TOWNSHIP, Mich., April 09, 2024 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its first quarter 2024 financial results before the market opens on Thursday, April 25.
  • The company will host a conference call for the investment community at 9 a.m.
  • The conference call is also available to the public via a live audio webcast .
  • Shortly after the call, a replay of the webcast will be available on the company’s website.

Telematics Market Is Prime for a Pull-Ahead Leader

Retrieved on: 
Tuesday, April 9, 2024
Verizon Communications, Environment, NexTraq, Risk, Satellite navigation, AI, TomTom, Investment, Safety, Marketing, Emotion

This underscores the opportunity for telematics brands to distinguish themselves in a competitive environment of commoditized solutions.

Key Points: 
  • This underscores the opportunity for telematics brands to distinguish themselves in a competitive environment of commoditized solutions.
  • Drawing on input from 1,000 fleet decision-makers, the Telematics Path to Purchase report sheds light on the intricate process of shopping for and acquiring telematics solutions, and decision-makers’ perspectives on the telematics solution market.
  • Further, fewer than 40% are familiar with the dedicated TSPs, including TomTom, Geotab, NexTraq, Omnitracs, MiX Telematics and Trimble.
  • “While larger fleets have driven initial adoption, the market is gradually shifting toward smaller fleets and mixed fleet businesses.

iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting

Retrieved on: 
Monday, April 8, 2024
Prevalence, Cardiovascular disease, Sudden death, Radiology, Blood, Risk, Physician, ICAD, Patient, Ageing, Stroke, Research, Breast, Angiography, Death, Woman, American College, Breast cancer, Literature, Prognosis, Moyamoya disease, ACC, Medical imaging

The 15-site prospective study included 2D screening mammograms from women ages 20 to 100, with a median age of 56.

Key Points: 
  • The 15-site prospective study included 2D screening mammograms from women ages 20 to 100, with a median age of 56.
  • “The ProFound BAC AI algorithm may provide a critical surrogate biomarker for women at risk of heart disease or stroke,” said Dana Brown, president and CEO of iCAD.
  • The study also suggests the ProFound Heart Health AI algorithm can standardize BAC detection, potentially improving efficiency and reducing variability among observers.
  • Early cardiovascular disease detection is key, as among asymptomatic women, the first manifestation of underlying coronary heart disease is often acute myocardial infarction (MI) or sudden death.

DB Roberts Welcomes Jeff Senter as Field Sales Manager for the Central United States.

Retrieved on: 
Monday, April 8, 2024
Chancellor University, Business administration, Accounting, Mentorship, Lake Erie College, Management

WILMINGTON, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- DB Roberts is thrilled to announce the appointment of Jeff Senter as the Central Field Sales Manager.

Key Points: 
  • WILMINGTON, Mass., April 08, 2024 (GLOBE NEWSWIRE) -- DB Roberts is thrilled to announce the appointment of Jeff Senter as the Central Field Sales Manager.
  • Residing in the Greater Cleveland area, Jeff is set to play a pivotal role in steering the Central United States Field Sales Team, overseeing operations spanning Ohio, Texas, and Wisconsin.
  • Jeff is fully committed to mentoring sales personnel, unlocking their full potential, and ensuring unparalleled support for customers in the region.
  • His exceptional leadership skills, coupled with his background and experience, make him the perfect fit to lead our central sales efforts,” says Courtney Lorimer, National Field Sales Manager at DB Roberts.

Zehnder’s Fortress Golf Course Professional Kyle Martin Named 2024 Michigan PGA Teacher and Coach of the Year

Retrieved on: 
Monday, April 8, 2024
Education, Woman, PGA, Golf, Publication, Fortification, Teaching, Tutoring

FRANKENMUTH, Mich., April 08, 2024 (GLOBE NEWSWIRE) -- Kyle Martin, Head Professional at the Zehnder’s Fortress Golf Course, has been named the 2024 Michigan Section Professional Golf Association (PGA) Teacher and Coach of the Year.

Key Points: 
  • FRANKENMUTH, Mich., April 08, 2024 (GLOBE NEWSWIRE) -- Kyle Martin, Head Professional at the Zehnder’s Fortress Golf Course, has been named the 2024 Michigan Section Professional Golf Association (PGA) Teacher and Coach of the Year.
  • Martin has served at the 18-hole championship Fortress golf course for nine years in Frankenmuth, Mich., located just 90 miles north of Detroit.
  • The Fortress is a division of Zehnder’s and is one of Michigan’s top 25 golf courses.
  • “We are extremely honored to have Kyle as part of our winning team,” said Fortress Director of Golf Nick Shelton.

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

Retrieved on: 
Sunday, April 7, 2024
Uric acid, Urinary tract infection, Anaphylaxis, Myocardial infarction, Common, Bronchitis, Patient, Atherosclerosis, FAHA, Cleveland Clinic, Bempedoic acid, Ezetimibe, Therapy, Anemia, Pain, MACE, Sinusitis, ACC, FOMA, FNLA, FACC, Obesity, Cardiovascular disease, Esperion Therapeutics, Abdominal pain, Risk, Gout, Spasm, Woman, American College, Body mass index, ESPR, Back pain, Outcome, ATP, Safety, Fatigue, Arthralgia, ANN, Angioedema, Kidney, Journal, Constipation, University, Adverse event, Pregnancy, CLEAR, Rash, MPH, Rupture, FDA, Molina Healthcare, JACC, Hypersensitivity, Health, Circulatory system, Tablet, CVD, Incidence, Diarrhea, Fetus, Gallstone, Diet, Excipient, Upper respiratory tract infection, Dietary supplement

ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced the presentation of results from three pre-specified subgroups from CLEAR Outcomes at the 2024 American College of Cardiology’s Annual Scientific Sessions (ACC.24): women, Hispanic/Latinx, and patients with obesity. These results align with the American College of Cardiology’s robust diversity, equity and inclusion programs to drive cultural change across the profession and ensure that the cardiovascular care team is as diverse as the patients they care for and that all patients are represented in cardiovascular research. The data also reinforce the mission of the ACC: transforming cardiovascular care for all.

Key Points: 
  • “Bempedoic acid is the only FDA approved non-statin LDL lowering therapy to demonstrate reductions in MACE in both primary prevention and secondary prevention patient populations.
  • The Hispanic population is the largest ethnic minority in the U.S., yet is a population historically underrepresented in clinical trials.
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.
  • CLEAR Outcomes is part of the CLEAR clinical research program for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet.

Rivalry Reports Preliminary Fourth Quarter and Year-End 2023 Results

Retrieved on: 
Friday, April 5, 2024
Fantasy, Growth, Entrepreneurship, Minority, Webcast, KPI, EDT, Acquisition, Bank statement, TAM, Generation Z, Finance Secretary (India), Traction, Ecosystem, Elasticity, NBA, Marketing, IOS, Multilateral, Gen

Rivalry is seeing a rise in demand to license its in-house casino games, accelerating the advancement of its B2B vertical.

Key Points: 
  • Rivalry is seeing a rise in demand to license its in-house casino games, accelerating the advancement of its B2B vertical.
  • TORONTO, April 05, 2024 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), the leading sportsbook and iGaming operator for Gen Z, today announced preliminary and unaudited financial results for the three and 12-month periods ended December 31, 2023.
  • “Rivalry exited 2023 as an increasingly diversified company – both geographically and across our product suite,” said Steven Salz, Co-Founder and CEO of Rivalry.
  • Management will host a conference call at 10:00 a.m. EDT on Friday, April 5, 2024 to discuss the Company’s preliminary unaudited year-end and fourth quarter 2023 financial results.